Jean-GabrielGriboul

Partner

Paris + 33.1.56.59.38.92

Jean-Gabriel Griboul has extensive experience in venture and growth capital, private equity, public and private M&A, and capital markets transactions.

Jean-Gabriel primarily represents high-growth listed and unlisted companies, their managers, as well as the private equity and industrial investors that finance them. He has acted as principal lawyer in a significant number of early to late-stage financing rounds, M&A transactions, initial public offerings (IPOs), rights issues, tender offers, and private placements, mainly for technology and life sciences companies.

Jean-Gabriel's recent experience includes the representations of: Adikteev, Adocia, AudioValley, Cubyn, Mauna Kea Technologies, Nanobiotix, Swile, TxCell, Verimatrix, and Voluntis. His recent investor-side representations include: Alven, BNP Paribas, Bpifrance, ChapsVision, Daphni, DN Capital, Elaia Partners, ETF Partners, Eurazeo/Idinvest, Goldman Sachs, Hedosophia, Index Ventures, Invus, New Alpha Asset Management, Omnes Capital, Open CNP, Orange, Portag3 Ventures, and Seventure Partners.

Examples of the transactions in which Jean-Gabriel has acted as lead lawyer include: the Nasdaq IPO of Nanobiotix; ChapsVision tender offer on Coheris; the sale of Drivy to Getaround; financings rounds of Swile; and Orange's investments in Jumia (AIG).

Experience

  • Swile raises $200 million in Series D financingJones Day advised Swile, a French-based tech company that offers digital solutions for employee rewards and benefits through a custom card and app, in connection with its $200 million Series D round of financing led by SoftBank, alongside existing investors Index Ventures, Eurazeo and Bpifrance Large Venture.
  • Elaia Partners leads €6 million financing round of ElevoJones Day represented Elaia Partners in connection with the €6 million financing round of Elevo, the people management platform that increases the employee experience and enables people leaders to develop engaged and high performing teams.
  • Creadev, DN Capital, and Adélie participate in €31 million Series B financing round of FoodlesJones Day advised Creadev, DN Capital, and Adélie as historic investors in the €31 million Series B round of financing of Foodles, a French company providing catering solution based on connected fridges and pre-orders, led by InfraVia with Bpifrance Large Venture also participating.
  • Planity raises €30 million in Series B financing roundJones Day represented Planity, a French company specialized in the edition, design, and marketing of appointment making, payments, point of sales, product management, and customer tools dedicated to professionals in the beauty industry, in connection with its €30 million Series B financing round led by Gaia Capital Partners, alongside historical investors Crédit Mutuel Innovation, BPI Digital Venture, Alven, and Eiffel Investment Group.
  • Crane Venture Partners leads $4 million financing round of QoveryJones Day advised Crane Venture Partners, lead investor, in the $4 million financing round of Qovery, a platform helping developers to deploy their applications in the cloud, with Speedinvest and other business angels also participating.
  • Open CNP participates as co-investor in €16 million Series B financing round of YesWeHackJones Day represented Open CNP SAS as participating historical investor in the €16 million Series B round of financing of YesWeHack, a French-based company that develops a platform dedicated to connecting organizations with IT security needs and a community of competent people, led by la Banque des Territoires (Caisse des Dépôts et Consignations Group) and Eiffel Investment Group.
  • Elaia Partners manages €7 million financing round of Tilak HealthcareJones Day represented Elaia Partners in connection with the €7 million financing round of Tilak Healthcare, a pioneering company developing mobile games with medical modules to monitor patients with chronic ophthalmological conditions, managed by Elaia Partners, with participation of Swen Capital Partners, Matmut Innovation, and iBionext Growth Fund.
  • 2050.do, Bpifrance, and BNP Paribas participates in €5.5 million Series A financing round of Fleurs d'IciJones Day represented 2050.do, Bpifrance, and BNP Paribas, with Kalian Group also participating, in connection with the €5.5 million Series A financing round of Fleurs d'Ici, a French-based company engaged in the business of distributing and selling flowers based on a short and ethical circuit.
  • Nano raises €1.6 million in financing roundJones Day advised Nano Corp., a French company developing a breakthrough technology improving Cloud Service Providers and Telecom Operators Data Centers' visibility and monitoring capacities, in connection with its €1.6 million round of financing, led by Elaia Partners with Cartisa (Nano Corp.'s first business angel) also participating.
  • DJUST raises €4 million in seed round of financingJones Day represented DJUST, a French start-up company developing e-commerce and digital SaaS solutions compatible with different digital business models in connection with its €4 million seed round of financing led by Elaia Partners.
  • Yousign raises €30 million in Series A roundJones Day advised Yousign, a French-based trust service provider issuing electronic certificates and software publisher of an electronic signature application, in connection with its €30 million Series A round of financing led by Lead Edge Capital Management, LLC with existing investor eFounders also participating.
  • Cryptosense raises $4.8 million in funding roundJones Day advised Cryptosense SA, a cryptography lifecycle management platform, in the $4.8 million funding round led by Amadeus Capital Partners with participation from BGV and Elaia Partners.
  • Elaia Partners leads €4 million financing round of Mablink BioscienceJones Day represented Elaia Partners in connection with the €4 million seed round of financing of Mablink Bioscience, a company developing the next generation of antibody-drug conjugates (ADC) through its proprietary hydrophilic drug-linker PSARlink™ platform.
  • Unseenlabs raises €20 million in Series B funding roundJones Day advised Unseenlabs, a European leader in satellite radio frequency (RF) geolocation of ships at seas, in connection with its €20 million Series B round of financing.
  • Fintecture raises $7.5 million in seed round of financingJones Day represented Fintecture, a French company specialized in API gateway connecting businesses to bank, in its $7.5 million seed round of financing led by Target Global with Samaipata and Société Générale participating.
  • Portage Ventures (Sagard) invests in Pledg SASJones Day represented Portage Ventures (Sagard) in connection with its equity investment in Pledg SAS, a solution for payment in installments or deferred payments.
  • Elaia Partners and Majycc eSanté lead €2.5 million financing round of I-VirtualJones Day advised Elaia Partners and Majycc eSanté in connection with the €2.5 million round of financing of I-Virtual, a French-based company that is specialized in the development of software for non-contact measurement of physiological variables in the health and wellness sector.
  • Portage Ventures (Sagard) participates in €29 million funding round of AcheelJones Day represented Portage Ventures (Sagard) in the €29 million funding round of Acheel, a Paris, France based startup building a digital platform for selling non-life insurance products.
  • Omnes Capital participates in €5 million Series B financing round of ElistairJones Day advised Omnes Capital S.A.S. in the €5 million Series B round of financing of Elistair, a French company specialized in wired drones.
  • Cubyn raises €35 million in Series C financing roundJones Day advised Cubyn SAS, a French-based company specialized in collection, packing, and shipping of packages, in connection with its €35 million Series C round of financing led by Bpifrance and Idinvest.
  • Speaking Engagements

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • 7 janvier 2016
      Le private equity : quelles opportunités pour 2016 ?